Applied Genetic Tech (AGTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2022 | 06-2021 | 06-2020 | 06-2019 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,366 | 105,052 | 38,463 | 26,703 | 31,065 |
| Marketable Securities | 0 | 2,000 | 41,995 | 55,292 | 73,840 |
| Receivables | N/A | N/A | N/A | 13 | 210 |
| TOTAL | $49,561 | $109,707 | $82,964 | $84,284 | $109,124 |
| Non-Current Assets | |||||
| PPE Net | 4,714 | 4,658 | 4,311 | 4,430 | 5,254 |
| Investments And Advances | 7,807 | 8,000 | 8,096 | 1,945 | 1,980 |
| Intangibles | 1,433 | 1,287 | 1,098 | 1,013 | 968 |
| Other Non-Current Assets | 3,169 | 3,314 | 3,850 | 544 | 1,206 |
| TOTAL | $17,123 | $17,259 | $17,355 | $7,932 | $9,408 |
| Total Assets | $66,684 | $126,966 | $100,319 | $92,216 | $118,532 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,298 | 2,181 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,911 | 1,879 | 1,355 | 1,331 | 945 |
| Accrued Expenses | 11,727 | 14,500 | 10,502 | 8,024 | 7,155 |
| TOTAL | $25,207 | $19,714 | $12,963 | $9,355 | $14,395 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,122 | 17,727 | 9,677 | N/A | N/A |
| Deferred Revenues | N/A | N/A | N/A | N/A | 6,295 |
| Other Non-Current Liabilities | 2,878 | 3,717 | 6,625 | 4,152 | 4,345 |
| TOTAL | $12,000 | $21,444 | $16,340 | $4,152 | $4,955 |
| Total Liabilities | $37,207 | $41,158 | $29,303 | $13,507 | $19,350 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 67,632 | 42,860 | 25,858 | 18,218 | 18,129 |
| Common Shares | 51 | 43 | 25 | 18 | 18 |
| Retained earnings | -308,212 | -239,269 | -181,440 | -135,548 | -110,926 |
| Other shareholders' equity | -256 | -211 | -88 | -85 | -49 |
| TOTAL | $29,477 | $85,808 | $71,016 | $78,709 | $99,182 |
| Total Liabilities And Equity | $66,684 | $126,966 | $100,319 | $92,216 | $118,532 |